Search Results - "Lorent, N."

Exploring the use of exhaled breath as a diagnostic tool for pulmonary TB by Happaerts, M., Lorent, N., André, E.

“…Despite its historical decline, TB remains a significant cause of infectious disease-related global deaths. The lack of reliable diagnostic tests for…”
Get full text

Elevated serum calprotectin (S100A8/A9) in patients with severe asthma by Decaesteker, T., Bos, S., Lorent, N., Everaerts, S., Vanoirbeek, J., Bullens, D., Dupont, L. J.

“…Asthma is a heterogeneous disease consisting of several inflammatory phenotypes of which neutrophilic asthma is associated with poorer responses to classic…”
Get full text

National Survey on the Management of Adult Bronchiectasis in Belgium by Schoovaerts, K, Lorent, N, Goeminne, P, Aliberti, S, Dupont, L

“…The increasing prevalence and incidence of bronchiectasis leads to a substantial health care burden. Quality standards for the management of bronchiectasis…”
Get more information

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD by Everaerts, Stephanie, Lagrou, Katrien, Dubbeldam, Adriana, Lorent, Natalie, Vermeersch, Kristina, Van Hoeyveld, Erna, Bossuyt, Xavier, Dupont, Lieven J, Vanaudenaerde, Bart M, Janssens, Wim

“…Bronchiectasis-chronic obstructive pulmonary disease (COPD) overlap presents a possible clinical phenotype of COPD, but it is unclear why it develops in a…”
Get full text

Active tuberculosis screening of close contacts among the urban poor: a Cambodian experience by Lorent, N., Choun, K., Thai, S., Rigouts, L., Lynen, L.

Get full text

Systematic screening for drug-resistant tuberculosis with Xpert® MTB/RIF in a referral hospital in Cambodia by Lorent, N., Kong, C., Kim, T., Sam, S., Thai, S., Colebunders, R., Rigouts, L., Lynen, L.

“…SETTING: Limited access to drug susceptibility testing (DST) in referral hospitals contributes to delayed detection of multidrug-resistant tuberculosis…”
Get full text

Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis by Van de Kerkhove, C, Goeminne, P.C, Kicinski, M, Nawrot, T.S, Lorent, N, Van Bleyenbergh, P, De Boeck, K, Dupont, L.J

“…Abstract Introduction The efficacy of inhaled antibiotics to treat chronic Pseudomonas aeruginosa pulmonary infection in patients with cystic fibrosis (CF) has…”
Get full text

396 Agreement between patients' self-report and multidisciplinary CF professionals' proxy report of symptoms of anxiety and depression by Havermans, T, Lorent, N, Colpaert, K, Theunissen, B, Kinoo, D, Hollemans, G, Dupont, L

Get full text

Early lung ultrasound assessment for the prognosis of patients hospitalized for COVID-19 pneumonia. A pilot study by Kalkanis, A., Wauters, E., Testelmans, D., Yserbyt, J., Lorent, N., Louvaris, Z., Godinas, L., Van Mol, P., Wauters, J., Eleftheriou, M., Dooms, C.

“…SARS CoV-2 is an epidemic viral infection that can cause mild to severe lung involvement. Newly apprehended knowledge on thoracic imaging abnormalities and the…”
Get full text

116 Lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis: a possibility? by Lorent, N, Van Bleyenbergh, P, Colpaert, K, Vos, R, Schaevers, V, Havermans, T, Dupont, L

Get full text

Is frontloaded sputum microscopy an option in active tuberculosis case finding? by Lorent, N., Buyze, J., Kim, T., Kong, C., Van Deun, A., Colebunders, R., Thai, S., Lynen, L., Rigouts, L.

“…SETTING: Active tuberculosis (TB) case finding (ACF) in Phnom Penh, Cambodia using light-emitting diode fluorescence microscopy (FM).OBJECTIVE: To evaluate the…”
Get full text

Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience by Lorent, N., De Leyn, P., Lievens, Y., Verbeken, E., Nackaerts, K., Dooms, C., Van Raemdonck, D., Anrys, B., Vansteenkiste, J.

“…Background: The aim of this study was to analyse the outcome of surgically staged IIIA-N2 non-small-cell lung cancer (NSCLC) treated with induction…”
Get full text

WS09.1 Should we advocate a structured venous access policy in adults with CF? by Colpaert, K, Ruelens, C, Lorent, N, Van Bleyenbergh, P, Dupont, L.J

“…Background Peripherally Inserted Central Catheter (PICC) & Totally Implanted Access Device (TIVAD) are widely used to provide venous access for CF patients…”
Get full text

Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia by Choun, Kimcheng, Thai, Sopheak, Pe, Reaksmey, Lorent, Natalie, Lynen, Lutgarde, van Griensven, Johan

“…Background Given the lack of detailed studies on tuberculosis (TB) in patients on antiretroviral treatment (ART) in South-East Asia, we aimed to determine the…”
Get full text

Risk factors for delay in the diagnosis and treatment of tuberculosis at a referral hospital in Rwanda by LORENT, N, MUGWANEZA, P, MUGABEKAZI, J, GASANA, M, VAN BASTELAERE, S, CLERINX, J, VAN DEN ENDE, J

“…SETTING: Kigali University Hospital, the main referral centre for TB in Rwanda.OBJECTIVE: To evaluate delays in the diagnosis and treatment of tuberculosis…”
Get full text

Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease by De Man, J., Adriaenssens, N., Van Bleyenbergh, P., Happaerts, M., André, E., Spriet, I., Dupont, L., Lorent, N.

Get full text

Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB by Abbew, E.T., Laryea, R., Sorvor, F., Poku, Y.A., Lorent, N., Obiri-Yeboah, D., Lynen, L., Rigouts, L.

“…INTRODUCTION Non-tuberculous mycobacteria (NTM) are increasingly isolated in individuals with presumed/confirmed pulmonary TB. We aimed to estimate the…”
Get full text

P183 Elucidating the intrinsic defects in cystic fibrosis neutrophils by Da Silva Cunha, A.L., Blanter, M., Gouwy, M., Lorent, N., Boon, M., Struyf, S., Carlon, M.S.

Get full text

Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity by Vanderbeke, L., Van Mol, P., Van Herck, Y., De Smet, F., Humblet-Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M., Casaer, M., Dauwe, D., De Wever, W., Dooms, C., Dreesen, E., Emmaneel, A., Filtjens, J., Gouwy, M., Gunst, J., Hermans, G., Jansen, S., Lagrou, K., Liston, A., Lorent, N., Meersseman, P., Mercier, T., Neyts, J., Odent, J., Panovska, D., Penttila, P. A., Pollet, E., Proost, P., Qian, J., Quintelier, K., Raes, J., Rex, S., Saeys, Y., Sprooten, J., Tejpar, S., Testelmans, D., Thevissen, K., Van Buyten, T., Vandenhaute, J., Van Gassen, S., Velásquez Pereira, L. C., Vos, R., Weynand, B., Wilmer, A., Yserbyt, J., Garg, A. D., Matthys, P., Wouters, C., Lambrechts, D., Wauters, E., Wauters, J.

“…Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct…”
Get full text

RWD22 Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Management in Belgium: A Longitudinal Pharmacy Database Study by Peeters, E, van der Laan, R, Chevalier, P, Cai, R, Obradovic, M, Lorent, N

Get full text